GlassScriptPhysician profile
Nicolas Manriquez
NPI 1023281581
$4,079.67
in general payments reported to CMS, 2019-2025
20 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.22 · 2020: $967 · 2021: $46.38 · 2022: $112 · 2023: $1,723 · 2024: $750 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $931.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics, LLC. | $1,500.00 | 2023 | |
| Musculoskeletal Transplant Foundation INC. | $639.18 | 2020 | |
| Fusion Orthopedics USA, LLC | $576.58 | 2024-2025 | |
| Stryker Corporation | $523.19 | 2020-2024 | Augment Injectable, Spy-Phi System |
| Treace Medical Concepts, INC. | $155.87 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $146.14 | 2024-2025 | Nuzyra |
| Alafair Biosciences, INC. | $134.21 | 2022-2025 | Versawrap |
| Biotissue Holdings INC. | $69.60 | 2020 | |
| Bioventus LLC | $45.68 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.73 | 2022 | |
| Smith+Nephew, INC. | $33.94 | 2023 | Pico 7 |
| Innovation Technologies INC | $32.26 | 2025 | Irrisept |
| Assertio Therapeutics, INC. | $31.09 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $28.03 | 2022 | |
| Medinc of Texas | $26.01 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $23.63 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $22.46 | 2020 | |
| Fidia Pharma USA INC. | $22.38 | 2020 | |
| Amgen INC. | $15.71 | 2025 | Krystexxa |
| Integra Lifesciences Corporation | $14.98 | 2025 | Cytal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicolas Manriquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.